These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29532748)

  • 21. [Structure of the adenosine-bound conformation of the human adenosine A(2A) receptor].
    Lebon G; Tate CG
    Med Sci (Paris); 2011 Nov; 27(11):926-8. PubMed ID: 22130015
    [No Abstract]   [Full Text] [Related]  

  • 22. Adenosine A2A receptor agonists as anti-inflammatory agents.
    Sullivan GW
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1313-9. PubMed ID: 14758770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure-activity relationships of 2-hydrazinyladenosine derivatives as A(2A) adenosine receptor ligands.
    El-Tayeb A; Gollos S
    Bioorg Med Chem; 2013 Jan; 21(2):436-47. PubMed ID: 23245803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting adenosine receptors to prevent inflammatory skin diseases.
    Gessi S; Merighi S; Borea PA
    Exp Dermatol; 2014 Aug; 23(8):553-4. PubMed ID: 24961687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating lung inflammation with agonists of the adenosine A2A receptor: promises, problems and potential solutions.
    Trevethick MA; Mantell SJ; Stuart EF; Barnard A; Wright KN; Yeadon M
    Br J Pharmacol; 2008 Oct; 155(4):463-74. PubMed ID: 18846036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of A
    DeOliveira CC; Paiva Caria CR; Ferreira Gotardo EM; Ribeiro ML; Gambero A
    Eur J Pharmacol; 2017 Mar; 799():154-159. PubMed ID: 28202393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel approaches for targeting the adenosine A2A receptor.
    Yuan G; Gedeon NG; Jankins TC; Jones GB
    Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dipyridamole attenuates ischemia reperfusion induced acute kidney injury through adenosinergic A1 and A2A receptor agonism in rats.
    Puri N; Mohey V; Singh M; Kaur T; Pathak D; Buttar HS; Singh AP
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):361-8. PubMed ID: 26728617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
    Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.
    Zeng L; Guan M; Jin H; Liu Z; Zhang L
    Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of 7-(Prolinol-N-yl)-2-phenylamino-thiazolo[5,4-d]pyrimidines as Novel Non-Nucleoside Partial Agonists for the A2A Adenosine Receptor: Prediction from Molecular Modeling.
    Bharate SB; Singh B; Kachler S; Oliveira A; Kumar V; Bharate SS; Vishwakarma RA; Klotz KN; Gutiérrez de Terán H
    J Med Chem; 2016 Jun; 59(12):5922-8. PubMed ID: 27227326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic Role of the G Protein in Stabilizing the Active State of the Adenosine A
    Lee S; Nivedha AK; Tate CG; Vaidehi N
    Structure; 2019 Apr; 27(4):703-712.e3. PubMed ID: 30713025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cooperative cardioprotection through adenosine A1 and A2A receptor agonism in ischemia-reperfused isolated mouse heart.
    Urmaliya VB; Pouton CW; Ledent C; Short JL; White PJ
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):379-88. PubMed ID: 20930592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and energetic effects of A2A adenosine receptor mutations on agonist and antagonist binding.
    Keränen H; Gutiérrez-de-Terán H; Åqvist J
    PLoS One; 2014; 9(10):e108492. PubMed ID: 25285959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic Potentials of Adenosine Receptors: The State of The Art.
    Deb PK
    Curr Pharm Des; 2019; 25(26):2789-2791. PubMed ID: 31674891
    [No Abstract]   [Full Text] [Related]  

  • 36. A2A receptor ligands: past, present and future trends.
    Clementina M; Giuseppe S
    Curr Top Med Chem; 2010; 10(9):902-22. PubMed ID: 20370660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Communication over the network of binary switches regulates the activation of A2A adenosine receptor.
    Lee Y; Choi S; Hyeon C
    PLoS Comput Biol; 2015 Feb; 11(2):e1004044. PubMed ID: 25664580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. State-Targeting Stabilization of Adenosine A
    Mitsumoto M; Sugaya K; Kazama K; Nakano R; Kosugi T; Murata T; Koga N
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion.
    Gazoni LM; Laubach VE; Mulloy DP; Bellizzi A; Unger EB; Linden J; Ellman PI; Lisle TC; Kron IL
    J Thorac Cardiovasc Surg; 2008 Jan; 135(1):156-65. PubMed ID: 18179933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
    Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.